Call for proposals: SULSA High Throughput Screening Fund

Support is now available through the SULSA Translational Biology Theme
for researchers seeking to carry out high throughput small molecule screening of potential drug targets.

The deadline for this year’s applications is 17 July 2009. All proposals should show a contribution of matching funds at a minimum level of 20%.

Several Scottish universities offer excellent facilities and expertise for high throughput small molecule screening. But investigators can struggle to find sources of funding for screening, particularly when their research is at an early stage. The SULSA High Throughput Screening Fund was established to help bridge this gap in early drug discovery in Scottish Universities.

The choice of facility or laboratory for running the proposed screen is at the discretion of the applicant. In 2008, successful applicants chose to run their screens in collaboration with the Scottish Hit Discovery Facility (Dundee), Strathclyde Innovations in Drug Research, and the Centre for Biomolecular Sciences (St Andrews).

The successful 2008 projects – seven projects in total from six different
Scottish universities – tackled diverse biological targets for a wide range
of diseases and indications, including cancer, inflammatory disease, pain associated with nerve damage, trypanosomiasis (sleeping sickness) and pneumococcal infection.

The application form and full guidelines are available for download  here.